|
|
NOVEL GENE THERAPY STRATEGY FOR CEP290-LEBER CONGENITAL AMAUROSIS |
| 1R21EY029050-01 |
KHANNA, HEMANT |
NEI |
2018 |
|
|
REMOTE NEUROSTIMULATION WITH ULTRASOUND-ACTIVATED PIEZOELECTRIC NANOPARTICLES |
| 1R21EY029422-01 |
LUKE, GEOFFREY P. |
NEI |
2018 |
|
|
HEY: HISPANIC EYE STUDY |
| 1R21EY029605-01 |
MAESTRE, GLADYS E. |
NEI |
2018 |
|
|
NANOMEDICINE APPROACH TO COUNTERACT ACROLIEN-INDUCED BLINDNESS AND TOXICITY TO THE EYE |
| 1R21EY030233-01A1 |
MOHAN, RAJIV RAVINDRA |
NEI |
2018 |
|
|
TURBO EYE DROPS TO TREAT OCULAR TOXICITY AND BLINDNESS FROM SULFUR MUSTARD |
| 1R21EY030234-01 |
MOHAN, RAJIV RAVINDRA |
NEI |
2018 |
|
|
DEVELOPMENT OF A FIRST-IN-CLASS, POTENT AND SAFE, SMALL SYNTHETIC ANTI-ANGIOGENIC PEPTIDE FOR TREATMENT OF RETINOPATHY OF PREMATURITY |
| 1R43EY029210-01 |
HENKIN, JACK |
NEI |
2018 |
|
|
THE PHASE I/II RANDOMIZED, PROSPECTIVE, DOUBLE-BLINDED, SHAM-CONTROLLED CROSS-OVER STUDY OF INTRAVITREAL AUTOLOGOUS BONE MARROW CD34+ STEM CELL THERAPY FOR RETINAL VEIN OCCLUSION |
| 1UG1EY026876-01A1 |
PARK, SUSANNA S |
NEI |
2018 |
|
|
VILLAGE-INTEGRATED EYE WORKER TRIAL II (VIEW II) |
| 1UG1EY028097-01A1 |
KEENAN, JEREMY DAVID |
NEI |
2018 |
|
|
MECHANISMS OF IMMUNE HOMEOSTASIS AND REGULATION OF INTRAOCULAR INFLAMMATION |
| 1ZIAEY000372-18 |
EGWUAGU, CHARLES E |
NEI |
2018 |
|
|
VISION IN NHANES |
| 1ZIAEY000402-17 |
COTCH, MARY FRANCES |
NEI |
2018 |
